Vanberra Signal
Free trial

Cellino

Curated by Signal

Developer of autologous cell therapies

Life Sciences Technologycellinobio.com

Overview

Developer of autologous cell therapies. The company has developed an AI-guided laser editing platform, single-cell laser processing, and robotics to generate autologous induced pluripotent stem cells for regenerative medicines for diseases like Parkinson’s, diabetes, and heart disease.

Key facts

Founded
2017
Headquarters
Cambridge, United States
Stage
Sign up to view
Industry
Life Sciences Technology

Business model

4 products and services
Sign up to view

Contact

Email
Sign up to view

Open roles

3 roles

  • Automation Engineer I

    Cambridge, MA · On-site · Full-time

  • Genetic Engineer

    Cambridge, MA · On-site · Full-time

  • Bioengineer

    Cambridge, MA · On-site · Full-time

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

  • Anya

    Developer of nutritional products for women health

    Life Sciences TechnologyLong Beach, United States

  • GeneInsight

    Platform for genetic data analysis, interpretation and reporting

    Life Sciences TechnologyBoston, United States

  • ATOM Health

    Developer of health monitoring devices for providers

    Life Sciences TechnologyPalo Alto, United States

About Cellino

What does Cellino do?

Developer of autologous cell therapies.

Where is Cellino headquartered?

Cellino is headquartered in Cambridge, United States.

When was Cellino founded?

Cellino was founded in 2017.

Which sector is Cellino in?

Cellino operates in Life Sciences Technology.

Who are Cellino's competitors?

Companies similar to Cellino include Anya, GeneInsight, and ATOM Health.

Is Cellino hiring?

Yes. Cellino has 3 open roles listed on Vanberra Signal.